BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17713416)

  • 21. Molecules modulating gene transcription during muscle wasting in cancer, sepsis, and other critical illness.
    Aversa Z; Alamdari N; Hasselgren PO
    Crit Rev Clin Lab Sci; 2011; 48(2):71-86. PubMed ID: 21871000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
    Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
    Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPbeta in cultured myotubes.
    Yang H; Menconi MJ; Wei W; Petkova V; Hasselgren PO
    J Cell Biochem; 2005 Apr; 94(5):1058-67. PubMed ID: 15669015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
    Koopman R; Ryall JG; Church JE; Lynch GS
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
    Khal J; Tisdale MJ
    Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle.
    Penner G; Gang G; Sun X; Wray C; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2002 Feb; 282(2):R439-44. PubMed ID: 11792653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy with anabolic growth factors to prevent muscle atrophy.
    Schakman O; Thissen JP
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of glucocorticoid-induced myopathy.
    Schakman O; Gilson H; Thissen JP
    J Endocrinol; 2008 Apr; 197(1):1-10. PubMed ID: 18372227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy.
    Vazeille E; Codran A; Claustre A; Averous J; Listrat A; Béchet D; Taillandier D; Dardevet D; Attaix D; Combaret L
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1181-90. PubMed ID: 18812460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation.
    Hasselgren PO; Alamdari N; Aversa Z; Gonnella P; Smith IJ; Tizio S
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):423-8. PubMed ID: 20473154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal-transduction networks and the regulation of muscle protein degradation.
    Szewczyk NJ; Jacobson LA
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1997-2011. PubMed ID: 16125109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
    Al-Majid S; Waters H
    Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is TP53INP2 a critical regulator of muscle mass?
    Sala D; Zorzano A
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):234-9. PubMed ID: 25769060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid excess induces a prolonged leucine resistance on muscle protein synthesis in old rats.
    Rieu I; Sornet C; Grizard J; Dardevet D
    Exp Gerontol; 2004 Sep; 39(9):1315-21. PubMed ID: 15489054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones.
    Frost RA; Lang CH
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):255-63. PubMed ID: 15809527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein catabolism in acute renal failure.
    Franz M; Hörl WH
    Miner Electrolyte Metab; 1997; 23(3-6):189-93. PubMed ID: 9387114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy.
    Glover EI; Phillips SM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):630-4. PubMed ID: 20829685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical mechanisms of cellular catabolism.
    Tisdale MJ
    Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):401-5. PubMed ID: 12107376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory factors in age-related muscle wasting.
    Roth SM; Metter EJ; Ling S; Ferrucci L
    Curr Opin Rheumatol; 2006 Nov; 18(6):625-30. PubMed ID: 17053510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.